申请人:TREU Matthias
公开号:US20130190305A1
公开(公告)日:2013-07-25
The present invention encompasses compounds of general formula (I)
wherein the groups R
1
to R
6
, A, B, C, n, p, q and r are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.
本发明涵盖了一般式(I)的化合物,
其中R
1
到R
6
,A,B,C,n,p,q和r的定义如权利要求书中所述,
适用于治疗以细胞过度或异常增殖为特征的疾病,包含这种化合物的药物制剂以及它们作为药物的用途。